Company intelligence / Profile preview

Kashi

Ownership: Private
Development stage: Other

Overview

Kashi Clinical Laboratories is a commercial-stage clinical laboratory specializing in high-quality diagnostic and consultative services. Their offerings include molecular genetic testing to identify gene mutations or variations associated with disease, toxicology screening, virology diagnostics, HLA typing for transplantation compatibility, and specialized services such as bone marrow donor matching[3][7]. The company serves healthcare providers and patients seeking advanced laboratory assessments.

Therapeutic areas: OtherRare DiseasesInfectious Diseases
Modalities: Diagnostic testingMolecular genetic testingToxicology testingHLA typing and transplant diagnostics
Industry: Molecular Diagnostics

Partnerships

ThermoFisher Scientific

Beyond the preview

Go deeper on Kashi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kashi.

Explore the full profile